The Cancer Journal

Skip Navigation LinksHome > March/April 2008 - Volume 14 - Issue 2 > Surgical Resection of Hepatocellular Carcinoma
Cancer Journal:
doi: 10.1097/PPO.0b013e31816a5c1f
Special Issue on Hepatocellular Cancer: Original Articles

Surgical Resection of Hepatocellular Carcinoma

Duffy, John P. MD; Hiatt, Jonathan R. MD; Busuttil, Ronald W. MD, PhD

Collapse Box


The incidence of hepatocellular carcinoma (HCC) is increasing in the United States, primarily due to hepatitis C–related liver disease. Nearly 85%–90% of patients with HCC have underlying chronic liver disease or cirrhosis. Advanced tumor burden or prohibitive hepatic dysfunction precludes operative resection in most patients with HCC. Surgical resection is a treatment option with curative intent in patients with HCC not associated with cirrhosis or in patients with well-compensated liver disease. Tumor extent and hepatic function must be assessed preoperatively to avoid postresection hepatic failure, an often fatal condition that may require urgent liver transplantation. Appropriately selected candidates for liver resection have 5-year postoperative survival rates of 40%–70%, but recurrence rates approach 70%, especially in patients with cirrhosis. For this reason, the best resection for patients with HCC and cirrhosis is orthotopic liver transplantation, which has 5-year posttransplant survival rates of 65%–80% in well-selected candidates.

© 2008 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.